Cargando…

The quality control of medicines : proceedings of the 35th International Congress of Pharmaceutical Sciences, Dublin 1975 /

The Quality Control of Medicines documents the proceedings of the 35th International Congress of Pharmaceutical Sciences, organized by the Pharmaceutical Society of Ireland on behalf of the Federation Internationale Pharmaceutique, held in Dublin, on 1-5 September 1975. The theme chosen for the Cong...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: International Congress of Pharmaceutical Sciences Dublin, Ireland
Otros Autores: Deasy, P. B. (Editor ), Timoney, R. F. (Editor )
Formato: Electrónico Congresos, conferencias eBook
Idioma:Inglés
Publicado: Amsterdam ; New York : Elsevier, 1976.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 SCIDIR_ocn893630259
003 OCoLC
005 20231120111824.0
006 m o d
007 cr cnu---unuuu
008 141023s1976 ne a ob 101 0 eng d
040 |a OPELS  |b eng  |e rda  |e pn  |c OPELS  |d OCLCO  |d N$T  |d E7B  |d EBLCP  |d HEBIS  |d OCL  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d YDXCP  |d UAB  |d OCLCA  |d STF  |d OCLCO  |d OCLCA  |d UKAHL  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d COM  |d OCLCO  |d OCL  |d OCLCQ  |d OCLCO 
019 |a 897651356  |a 900884807 
020 |a 9781483165028  |q (electronic bk.) 
020 |a 1483165027  |q (electronic bk.) 
020 |z 9780444414540 
035 |a (OCoLC)893630259  |z (OCoLC)897651356  |z (OCoLC)900884807 
050 4 |a RS189  |b .C627 1975eb 
060 4 |a W3  |b IN541 1975q 
060 4 |a QV 771  |b I59 1975q 
072 7 |a MED  |x 071000  |2 bisacsh 
082 0 4 |a 615/.19  |2 22 
111 2 |a International Congress of Pharmaceutical Sciences  |n (35th :  |d 1975 :  |c Dublin, Ireland) 
245 1 4 |a The quality control of medicines :  |b proceedings of the 35th International Congress of Pharmaceutical Sciences, Dublin 1975 /  |c editors P.B. Deasy & R.F. Timoney. 
264 1 |a Amsterdam ;  |a New York :  |b Elsevier,  |c 1976. 
300 |a 1 online resource (xiii, 398 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
500 |a Sole distributors for the U.S.A. and Canada: Elsevier/North-Holland, New York, N.Y. 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
505 0 |a Front Cover; The Quality Control of Medicines; Copyright Page; Introduction; List of contributors; Table of Contents; Inaugural address; The quality control of medicines: A national and international responsibility; Part I: Main symposium. The basis for the quality control of medicines; Chapter 1. Chemical And Physical Aspects Of The Control Of Medicines; RESEARCH AND DEVELOPMENT; PHARMACEUTICAL PREPARATIONS; AUTOMATION; CONCLUSION; SUMMARY; Chapter 2. Biological Aspects Of The Control Of Medicines; ANTIGEN ANTIBODY REACTION; REFERENCES. 
505 8 |a Chapter 3. New concepts and standards of quality control as applied to controlled drug delivery systemsINTRODUCTION; QUALITY STANDARDS AND CONTROL METHODS FOR POLYMERIC MATERIALS; STANDARDS AND CONTROL METHODS IN DELIVERY SYSTEM MANUFACTURING OPERATIONS; STERILIZATION METHODS AND STERILITY STANDARDS; ""FUNCTIONALITY"": CONTROL METHODS AND STANDARDS; CONCLUSIONS; SUMMARY; Chapter 4. Storage problems associated with the control of medicines; SUPERVISION AND PROLONGATION OF STORABILITY; REFERENCES; Chapter 5. International problems in the control of medicines; Part II: Parallel symposia. 
505 8 |a Section 1: Physicochemical analysisChapter6. Spectral methods and in particular spectrofluorimetry; RECALL OF THE FUNDAMENTAL PRINCIPLES; INTRODUCTION TO THE EXPERIMENTAL METHOD; CHARACTERISTICS OF FLUORESCENT MOLECULES; ANALYTICAL APPLICATIONS; COMPARISON OF FLUORESCENCE WITH OTHER SPECTRAL METHODS; ENVIRONMENTAL EFFECTS AND LIMITATIONS; CONCLUSIONS; ACKNOWLEDGEMENTS; REFERENCES; Chapter7. The uses of mass spectrometry in the quality control of drugs; INTRODUCTION; DETECTION LIMIT, IDENTIFICATION LIMIT AND SAMPLE AMOUNTS. DERIVATISATION-REACTIONS; USES IN THE QUALITY CONTROL OF DRUGS. 
505 8 |a PROCEDURE FOR MASS SPECTROMETRIC IONISATIONCOMBINATIONS OF MASS SPECTROMETRY WITH CHROMATOGRAPHIC SEPARATION PROCEDURES; REFERENCES; Chapter8. Microwave discharge and afterglow excited emission spectra fordetection in gas chromatography; THE MICROWAVE GAS DISCHARGE; AFTERGLOW EXCITED MOLECULAR EMISSION SPECTRA; REFERENCES; Chapter9. Automation in pharmaceutical analysis; DATA PROCESSING IN THE ADMINISTRATIVE ASPECT OF PHARMACEUTICAL QUALITY CONTROL; DATA PROCESSING IN THE LABORATORY; AUTOMATIC ANALYSERS; PREFERRED RANGES FOR THE USE OF AUTOMATIC ANALYSERS; CONCLUDING REMARKS; REFERENCES. 
505 8 |a Section 2: Microbiological aspectsChapter10. Testing procedures for sterile products; INTRODUCTION; CONCLUSIONS; REFERENCES; Chapter11. Microbiological aspects in the control of non-sterile products; INTRODUCTION; MICROBIOLOGICAL PURITY-STANDARDS OF NON-STERILE PRODUCT; PRODUCT; MICROBIOLOGICAL ASPECTS IN THE DEVELOPMENT OF A PRODUCT; QUALITY ASSURANCE SYSTEM; REFERENCES; Chapter12. Preservation and sterility of ophthalmic preparations and devices; STERILITY REQUIREMENTS FOR OPHTHALMIC PREPARATIONS; WHEN AND WHY IS PRESERVATION REQUIRED?; THE FINAL CONTAINER; REFERENCES. 
520 |a The Quality Control of Medicines documents the proceedings of the 35th International Congress of Pharmaceutical Sciences, organized by the Pharmaceutical Society of Ireland on behalf of the Federation Internationale Pharmaceutique, held in Dublin, on 1-5 September 1975. The theme chosen for the Congress was """"the basis for the quality control of medicines"""", because of the importance and relevance of quality control in the production and distribution of medicines at national and international levels. This volume is arranged according to the manner in which the theme of the Congress was dev 
650 0 |a Pharmaceutical industry  |x Quality control  |v Congresses. 
650 0 |a Quality control. 
650 2 |a Pharmaceutical Preparations  |x standards  |0 (DNLM)D004364Q000592 
650 2 |a Quality Control  |0 (DNLM)D011786 
650 6 |a Industrie pharmaceutique  |0 (CaQQLa)201-0042410  |x Qualit�e  |0 (CaQQLa)201-0380200  |x Contr�ole  |0 (CaQQLa)201-0380200  |v Congr�es.  |0 (CaQQLa)201-0378219 
650 6 |a Qualit�e  |x Contr�ole.  |0 (CaQQLa)201-0072623 
650 7 |a quality control.  |2 aat  |0 (CStmoGRI)aat300056087 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a Quality control  |2 fast  |0 (OCoLC)fst01084966 
650 7 |a Pharmaceutical industry  |x Quality control  |2 fast  |0 (OCoLC)fst01060169 
655 2 |a Congress  |0 (DNLM)D016423 
655 7 |a proceedings (reports)  |2 aat  |0 (CStmoGRI)aatgf300027316 
655 7 |a Conference papers and proceedings  |2 fast  |0 (OCoLC)fst01423772 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congr�es.  |2 rvmgf  |0 (CaQQLa)RVMGF-000001049 
700 1 |a Deasy, P. B.,  |e editor. 
700 1 |a Timoney, R. F.,  |e editor. 
776 0 8 |i Print version:  |a International Congress of Pharmaceutical Sciences (35th : 1975 : Dublin, Ireland).  |t Quality control of medicines  |z 0444414541  |w (DLC) 76677252  |w (OCoLC)2725756 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780444414540  |z Texto completo